Skip to main content

Table 3 Pairwise comparisons of each intervention for the LUTS (bottom-left for pelvic pain and top-right for dysuria)

From: Comparison of treatments for preventing lower urinary tract symptoms after BCG immunotherapy of bladder tumors : a systematic review and network meta-analysis

Celecoxib

0.15

(0.01,2.80)

0.75

(0.07,7.68)

1.73

(0.23,13.20)

0.36

(0.02,5.38)

1.25

(0.29,5.47)

6.50

(0.36,118.33)

Levofloxacin

4.86

(0.09,275.01)

11.23

(0.23,537.29)

2.36

(0.03,199.27)

8.12

(0.27,246.61)

1.34

(0.13,13.74)

0.21

(0.00,11.65)

Oxybutynin

2.31(0.27,19.57)

0.49

(0.01,20.01)

1.67

(0.13,21.37)

0.58

(0.08,4.43)

0.09

(0.00,4.26)

0.43

(0.05,3.66)

Phenazopyridine

0.21

(0.01,7.23)

0.72

(0.07,7.11)

2.75

(0.19,40.68)

0.42

(0.01,35.67)

2.06

(0.05,84.55)

4.75

(0.14,163.19)

Placebo

3.44

(0.15,80.24)

0.80

(0.18,3.50)

0.12

(0.00,3.74)

0.60

(0.05,7.64)

1.38

(0.14,13.58)

0.29

(0.01,6.79)

Prulifloxacin